4D Molecular Therapeutics Inc at Bank of America Healthcare Conference Transcript
Okay, everybody. Good morning. Welcome to our continuing session for the Bank of America Healthcare Conference.
Our next presenting company is 4D Molecular Therapeutics. Presenting for 4D this morning is CEO, David Kirn. David, good morning. Welcome to Bank of America's Conference.
Good morning. Thanks for having us.
So maybe we can start with an overview of the company, kind of what your differentiating points are? And then we can go into some more detailed questions if that works.
Yes, absolutely. So great to see everybody. I'm David Kirn, Cofounder and CEO of 4D Molecular Therapeutics. So we're a next-generation AAV gene therapy company. We leverage the power of directed evolution to create highly targeted and optimized products for a variety of both
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |